Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hellmann

Showing results (21-30 of 116) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|November 1, 1982
Histamine receptor antagonism and anti-tumour activityM Collins, K Hellmann
Deutsche Medizinische Wochenschrift (1946)|October 13, 1978
[ICRF 159--a cytostatic substance]K Hellmann, K Rieche
Cancer Treatment Reviews|December 1, 1991
Radiotherapeutic enhancement by razoxaneK Hellmann, W Rhomberg
Journal of the National Cancer Institute|September 21, 1988
MOF as control arm for NSABP adjuvant chemotherapy trialK Hellmann, J Gilbert
Clinical & Experimental Metastasis|January 1, 1983
Enhanced cerebrovascular permeability by Metrazol: significance for brain metastasesN Greig, K Hellmann
Clinical & Experimental Metastasis|April 1, 1983
Antitumor effect of RA233 alone and combined with radiotherapyX T Li, K Hellmann
Journal of the National Cancer Institute|March 1, 1970
Effect of ICRF159 on the mammalian cell cycle: significance for its use in cancer chemotherapyK Hellmann, E O Field
Nursing Times|April 11, 1974
Cancer chemotherapy todayK Hellmann, S E James
British Journal of Cancer|July 1, 1973
in vitro effects of ICRF 159K Hellmann, R C Hallowes
Trends in Ecology & Evolution|January 4, 2025
Integrating social learning, social networks, and non-parental transgenerational plasticityJennifer K Hellmann, Andrew Sih
Pageof 12

Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|November 1, 1982
Histamine receptor antagonism and anti-tumour activityM Collins, K Hellmann
Deutsche Medizinische Wochenschrift (1946)|October 13, 1978
[ICRF 159--a cytostatic substance]K Hellmann, K Rieche
Cancer Treatment Reviews|December 1, 1991
Radiotherapeutic enhancement by razoxaneK Hellmann, W Rhomberg
Journal of the National Cancer Institute|September 21, 1988
MOF as control arm for NSABP adjuvant chemotherapy trialK Hellmann, J Gilbert
Clinical & Experimental Metastasis|January 1, 1983
Enhanced cerebrovascular permeability by Metrazol: significance for brain metastasesN Greig, K Hellmann
Clinical & Experimental Metastasis|April 1, 1983
Antitumor effect of RA233 alone and combined with radiotherapyX T Li, K Hellmann
Journal of the National Cancer Institute|March 1, 1970
Effect of ICRF159 on the mammalian cell cycle: significance for its use in cancer chemotherapyK Hellmann, E O Field
Nursing Times|April 11, 1974
Cancer chemotherapy todayK Hellmann, S E James
British Journal of Cancer|July 1, 1973
in vitro effects of ICRF 159K Hellmann, R C Hallowes
Trends in Ecology & Evolution|January 4, 2025
Integrating social learning, social networks, and non-parental transgenerational plasticityJennifer K Hellmann, Andrew Sih
Pageof 12